CASI Pharmaceuticals: Can The Stock Climb Further?

1:45 pm ET, 04 Apr 2018

CASI Pharmaceuticals (NASDAQ: CASI) provides pharmaceutical products and innovative oncology therapeutics to patients at affordable prices. There was over 287% surge in its stock price in the last three months.  But what does the future hold for this stock?

Here is what you need to know about CASI. 

The company is headquartered in Rockville, Maryland, and its R&D operations are in Beijing, China. EVOMELA, MARQIBO, and ZEVALIN are a part of its FDA approved product pipeline. CASI has plans to commercialize a product subset in China after the pending ANDAs (abbreviated new drug applications) get approved by FDA. 

What do you know about CASI's drugs?

CASI has a proprietary drug that is in Phase 2 of clinical development, and certain other drugs are in immuno-oncology preclinical development.  

There is a risk that CASI might get delisted from NASDAQ Capital Market if it doesn’t raise sufficient capital for its operational requirements. The stock price has been volatile lately, because of uncertainties in clinical trials or their delays, potential product failures and CASI’s reliance on 3rd parties for drug launch.  

What are the future prospects for the CASI stock? Per Finstead Research, the average analyst price target is $4.50, which is below its current market price.

CASI Pharmaceuticals has negative valuation ratios, which is an indication that the company is unprofitable.  Investing in the company's shares is highly speculative.

CASI Pharmaceuticals, Inc. (CASI) Stock Guide

Updated at: 1:23 pm ET, 17 Sep 2020

Before we start: if you're looking for CASI stock price, you can quickly find it out by visiting Finny and typing "CASI quote". If you're looking for a quick scoop on CASI stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "CASI". You'll get all this info in one place. Or you can just type "CASI news" to get the latest stock news.

Looking to buy or sell CASI Pharmaceuticals, Inc. (CASI)? Interested in getting the full scoop on CASI, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this CASI stock guide, we'll address key questions about CASI, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are CASI earnings?
2. What is CASI stock forecast (i.e., prediction)?
3. CASI buy or sell? What is CASI Finny Score?
4. What are the reasons to buy CASI? Why should I buy CASI stock?
5. What are the reasons to sell CASI? Why should I sell CASI stock?
6. What are CASI key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are CASI earnings?

CASI trailing 12-month earnings per share (EPS) is -$0.40.

Analyst Predictions

2. What is CASI stock forecast (i.e., prediction)?

Based on CASI analyst price targets, CASI stock forecast is $3.20 (for a year from now). That means the average analyst price target for CASI stock is $3.20. The prediction is based on 2 analyst estimates.

The low price target for CASI is $2.89, while the high price target is $3.50.

CASI analyst rating is Buy.

Analysis

3. CASI buy or sell? What is CASI Finny Score?

#{finnyScore:null}Our quantitative analysis shows 3 reasons to buy and 0 reasons to sell CASI. CASI doesn’t have an assigned Finny Score, because we don’t have sufficient data points to score the stock.

4. What are the reasons to buy CASI? Why should I buy CASI stock?

Here are the reasons to buy CASI stock:

5. What are the reasons to sell CASI? Why should I sell CASI stock?

We can’t think of any good reason to sell this stock, which doesn’t mean they don’t exist.

Key Stats

6. What are CASI key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for CASI:

Metrics CASI
Price $1.52
Average Price Target / Upside $3.20 / 109.84%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 51
Market Cap $204.51M
Forward P/E Ratio -8.25
Price/Book Ratio 20.03
Revenue (TTM) $10.21M
YoY Quarterly Revenue Growth N/A
Profit Margin 0.00%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us